Evaluating the Risk of Adverse Events in Patients With Psoriasis Treated With Interleukin Inhibitors Compared With the General Population and Systemic-Naive Patients With Psoriasis

被引：0
|
作者：
Wu, Jashin J. [1 ]
Scotto, Julie [2 ]
Davidson, David [2 ]
Patel, Vardhaman [2 ]
Wei, Zhongyuan [2 ]
Srivastava, Abhishek [3 ]
Potdukhe, Vaishnavi [3 ]
Seigel, Lauren [2 ]
机构：
[1] Univ Miami, Miller Sch Med, Coral Gables, FL USA
[2] Bristol Myers Squibb, New York, NY USA
[3] Mu Sigma, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43775
引用
收藏
页码：AB163 / AB163
页数：1
相关论文
共 50 条
  • [11] Risk of developing cancer among psoriasis patients as compared to non-psoriasis patients
    Gulliver, W.
    Gladney, N.
    Collins, K.
    Morrissey, A.
    MacDonald, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 13 - 13
  • [12] Adverse Cardiovascular Events In Patients With Psoriasis And Psoriatic Arthritis
    Ottensoser, Molly
    Berger, Jeffrey
    Garshick, Michael S.
    CIRCULATION, 2022, 145
  • [13] Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis
    Bissonnette, Robert
    Kerdel, Francisco
    Naldi, Luigi
    Papp, Kim
    Galindo, Claudia
    Langholff, Wayne
    Tang, K. L.
    Szapary, Philippe
    Fakharzadeh, Steven
    Srivastava, Bhaskar
    Goyal, Kavitha
    Gottlieb, Alice B.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (10) : 1002 - 1013
  • [14] Relative Risk of Myocardial Infarction for Canadian Patients with Psoriasis Treated Systemically as Compared to Patients Treated with Phototherapy
    Levesque, Annie
    Bissonnette, Robert
    Prefontaine, Sophie
    Lapierre, Marie-Eve
    Lachaine, Jean
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 71 - 71
  • [15] Mortality in Patients with Psoriatic Arthritis Compared to Patients with Rheumatoid Arthritis, Psoriasis Alone, and the General Population
    Ogdie, Alexis
    Haynes, Kevin
    Troxel, Andrea
    Love, Thorvardur
    Choi, Hyon K.
    Gelfand, Joel
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1081 - S1082
  • [16] THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES
    Mason, Kayleigh
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 33 - 33
  • [17] Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors
    Kridin, Khalaf
    Schonmann, Yochai
    Solomon, Arie
    Damiani, Giovanni
    Bitan, Dana Tzur
    Onn, Erez
    Weinstein, Orly
    Cohen, Arnon Dov
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2014 - 2020
  • [18] Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States
    Kimball, A. B.
    Schenfeld, J.
    Accortt, N. A.
    Anthony, M. S.
    Rothman, K. J.
    Pariser, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (05) : 1183 - 1190
  • [19] Malignancies in ustekinumab-treated psoriasis patients: comparisons with the general US population
    Papp, K.
    Krueger, G. G.
    Rustin, M. H. A.
    Healy, E.
    Yeilding, N.
    Szapary, P.
    Hsu, M. C.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 31 - 31
  • [20] Serious adverse events in the placebo group of trials evaluating systemic treatment in plaque psoriasis
    Afach, S.
    Chaimani, A.
    Penso, L.
    Brouste, E.
    Sbidian, E.
    Le Cleach, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 91 - 91
12345